• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎和多发性硬化患者复发期脑脊液中 BAFF 和 APRIL 水平。

Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.

机构信息

Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

出版信息

J Clin Immunol. 2012 Oct;32(5):1007-11. doi: 10.1007/s10875-012-9709-9. Epub 2012 May 30.

DOI:10.1007/s10875-012-9709-9
PMID:22644841
Abstract

BACKGROUND

BAFF (B-cell activating factor of the tumor necrosis factor family) and APRIL (a proliferation-inducing ligand) are two of the major survival factors for B cells. Many studies have shown that BAFF levels were elevated in MS patients. However, whether the levels of CSF BAFF/APRIL increased in NMO patients was still unclear.

OBJECTIVE

To measure the CSF BAFF and APRIL concentration of in NMO patients, and explore their relationship with disease activity in NMO.

METHODS

CSF BAFF and APRIL was measured by an enzyme-linked immunosorbent assay (ELISA) in NMO (n = 22), MS (n = 18) patients and controls (n = 14).

RESULTS

Concentration of BAFF and APRIL in NMO patients were significantly higher than MS and controls. CSF BAFF and APRIL levels in controls were also lower than MS. Both NMO and MS revealed an increased disease disability with increased CSF BAFF. CSF APRIL was associated with EDSS scores in NMO, but not found in MS.

CONCLUSIONS

BAFF/APRIL system considered important for aggressive B cells and T-cell responses, and may stimulates B cells and T cell activation in acute relapse of NMO and MS. In NMO patients, CSF BAFF and APRIL may be key factors of B cell immune response and reflect disease severity.

摘要

背景

BAFF(肿瘤坏死因子家族中的 B 细胞激活因子)和 APRIL(增殖诱导配体)是 B 细胞的两个主要存活因子。许多研究表明,MS 患者的 BAFF 水平升高。然而,NMO 患者 CSF 中的 BAFF/APRIL 水平是否增加仍不清楚。

目的

测量 NMO 患者 CSF 中的 BAFF 和 APRIL 浓度,并探讨其与 NMO 疾病活动度的关系。

方法

采用酶联免疫吸附试验(ELISA)检测 NMO(n=22)、MS(n=18)患者和对照组(n=14)的 CSF BAFF 和 APRIL 浓度。

结果

NMO 患者的 BAFF 和 APRIL 浓度明显高于 MS 和对照组。对照组的 CSF BAFF 和 APRIL 水平也低于 MS。无论是 NMO 还是 MS,随着 CSF BAFF 的增加,疾病残疾程度都有所增加。CSF APRIL 与 NMO 的 EDSS 评分相关,但在 MS 中未发现。

结论

BAFF/APRIL 系统被认为对侵袭性 B 细胞和 T 细胞反应很重要,可能在 NMO 和 MS 的急性复发中刺激 B 细胞和 T 细胞的激活。在 NMO 患者中,CSF BAFF 和 APRIL 可能是 B 细胞免疫反应的关键因素,并反映疾病的严重程度。

相似文献

1
Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.视神经脊髓炎和多发性硬化患者复发期脑脊液中 BAFF 和 APRIL 水平。
J Clin Immunol. 2012 Oct;32(5):1007-11. doi: 10.1007/s10875-012-9709-9. Epub 2012 May 30.
2
[Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].视神经脊髓炎患者血清及脑脊液中B细胞活化因子的研究
Nan Fang Yi Ke Da Xue Xue Bao. 2015 Mar;35(3):380-3.
3
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.在白种人群中,视神经脊髓炎的脑脊液中 B 细胞激活因子呈优势增加。
Mult Scler. 2010 Dec;16(12):1453-7. doi: 10.1177/1352458510380416. Epub 2010 Oct 8.
4
Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.视神经脊髓炎缓解期C-X-C基序配体13和B细胞活化因子水平升高。
Brain Behav. 2017 Mar 10;7(4):e00648. doi: 10.1002/brb3.648. eCollection 2017 Apr.
5
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.复发期间,多发性硬化症和视神经脊髓炎患者脑脊液中的尿胰蛋白酶抑制剂水平降低。
Neurochem Int. 2015 Feb;81:28-31. doi: 10.1016/j.neuint.2014.12.008. Epub 2014 Dec 30.
6
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.未经治疗的多发性硬化症患者脑脊液中 BAFF 和 APRIL 的水平。
J Neuroimmunol. 2010 Mar 30;220(1-2):104-7. doi: 10.1016/j.jneuroim.2010.01.011. Epub 2010 Feb 11.
7
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.视神经脊髓炎中调节功能受损和鞘内 B 细胞激活增强:与多发性硬化症不同。
Mult Scler. 2013 Mar;19(3):289-98. doi: 10.1177/1352458512454771. Epub 2012 Aug 3.
8
Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.与抗中性粒细胞胞质抗体相关的肥厚性硬脑膜炎发病机制相关的脑脊液生物标志物。
Clin Rheumatol. 2020 Jun;39(6):1803-1811. doi: 10.1007/s10067-020-04971-2. Epub 2020 Feb 8.
9
Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.神经精神性系统性红斑狼疮患者脑脊液中增殖诱导配体(APRIL)水平升高。
Scand J Rheumatol. 2011;40(5):363-72. doi: 10.3109/03009742.2010.550900. Epub 2011 May 18.
10
Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.视神经脊髓炎和多发性硬化症患者脑脊液中的白细胞介素 21 水平。
Can J Neurol Sci. 2012 Nov;39(6):813-20. doi: 10.1017/s0317167100015663.

引用本文的文献

1
Advancing Treatment in Pediatric Multiple Sclerosis: The Promise of B-Cell-Targeting Therapies.推进儿童多发性硬化症的治疗:B细胞靶向疗法的前景
Int J Mol Sci. 2025 Jun 22;26(13):5989. doi: 10.3390/ijms26135989.
2
Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review.利妥昔单抗和泰利奇普在难治性抗N-甲基-D-天冬氨酸受体脑炎和髓鞘少突胶质细胞糖蛋白相关脱髓鞘疾病中的序贯治疗成功:一例报告及文献综述
Front Immunol. 2025 Feb 6;16:1509143. doi: 10.3389/fimmu.2025.1509143. eCollection 2025.
3
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective.

本文引用的文献

1
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.红斑狼疮患者 BAFF 水平升高与急性期反应物相关,与 BAFF 遗传无关:病例对照研究。
Rheumatology (Oxford). 2011 Dec;50(12):2197-205. doi: 10.1093/rheumatology/ker282. Epub 2011 Oct 8.
2
The immunopathophysiology of multiple sclerosis.多发性硬化症的免疫病理生理学。
Neurol Clin. 2011 May;29(2):257-78. doi: 10.1016/j.ncl.2010.12.009.
3
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
多发性硬化症中B细胞活化的脑脊液生物标志物:临床视角
J Neurol. 2025 Feb 17;272(3):211. doi: 10.1007/s00415-025-12907-6.
4
The Latest Progress in the Application of Telitacicept in Autoimmune Diseases.泰它西普在自身免疫性疾病中的应用最新进展
Drug Des Devel Ther. 2024 Dec 7;18:5811-5825. doi: 10.2147/DDDT.S493923. eCollection 2024.
5
Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights.中枢神经系统结节病中的脑脊液细胞因子和趋化因子谱:诊断和免疫病理见解。
Ann Neurol. 2024 Oct;96(4):704-714. doi: 10.1002/ana.27024. Epub 2024 Jul 19.
6
Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review.视神经脊髓炎谱系障碍的可溶性生物标志物:一篇综述
Front Neurol. 2024 May 16;15:1415535. doi: 10.3389/fneur.2024.1415535. eCollection 2024.
7
Choroidal, retinal, and optic nerve changes in rheumatoid arthritis and primary sjogren's syndrome patients: comparıson with each other and healthy subjects.类风湿关节炎和原发性干燥综合征患者的脉络膜、视网膜和视神经变化:与彼此和健康受试者的比较。
Int Ophthalmol. 2024 Feb 7;44(1):24. doi: 10.1007/s10792-024-02970-9.
8
Excessive MALAT1 promotes the immunologic process of neuromyelitis optica spectrum disorder by upregulating BAFF expression.过量的MALAT1通过上调BAFF表达促进视神经脊髓炎谱系障碍的免疫过程。
Transl Neurosci. 2023 Oct 17;14(1):20220306. doi: 10.1515/tnsci-2022-0306. eCollection 2023 Jan 1.
9
Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues.自身免疫组织浸润的分泌抗体细胞的异质性。
Front Immunol. 2023 Feb 21;14:1111366. doi: 10.3389/fimmu.2023.1111366. eCollection 2023.
10
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.髓鞘少突胶质细胞糖蛋白相关疾病和水通道蛋白 4 抗体阳性视神经脊髓炎谱系疾病外周炎症反应增加。
Front Immunol. 2022 Nov 14;13:1037812. doi: 10.3389/fimmu.2022.1037812. eCollection 2022.
多发性硬化症的诊断标准:2010 年麦克唐纳标准修订版。
Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
4
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.多发性硬化症:脑脊液中的 BAFF 和 CXCL13。
Mult Scler. 2011 Jul;17(7):819-29. doi: 10.1177/1352458511398887. Epub 2011 Mar 3.
5
[BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity].干燥综合征和系统性红斑狼疮中的BAFF/APRIL信号通路:与慢性炎症和疾病活动的关系
Reumatismo. 2010 Oct-Dec;62(4):259-65. doi: 10.4081/reumatismo.2010.259.
6
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.在白种人群中,视神经脊髓炎的脑脊液中 B 细胞激活因子呈优势增加。
Mult Scler. 2010 Dec;16(12):1453-7. doi: 10.1177/1352458510380416. Epub 2010 Oct 8.
7
Humoral autoimmunity in multiple sclerosis.多发性硬化症中的体液自身免疫。
J Neurol Sci. 2011 Jul 15;306(1-2):180-2. doi: 10.1016/j.jns.2010.08.009. Epub 2010 Sep 3.
8
EFNS guidelines on diagnosis and management of neuromyelitis optica.EFNS 指南:视神经脊髓炎的诊断与管理。
Eur J Neurol. 2010 Aug;17(8):1019-32. doi: 10.1111/j.1468-1331.2010.03066.x. Epub 2010 Jun 7.
9
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.未经治疗的多发性硬化症患者脑脊液中 BAFF 和 APRIL 的水平。
J Neuroimmunol. 2010 Mar 30;220(1-2):104-7. doi: 10.1016/j.jneuroim.2010.01.011. Epub 2010 Feb 11.
10
Neuromyelitis optica and the evolving spectrum of water channel autoimmunity: a new direction.视神经脊髓炎与水通道自身免疫性疾病的演变谱系:一个新方向。
Eur J Neurol. 2009 Apr;16(4):433-5. doi: 10.1111/j.1468-1331.2008.02385.x.